Emitasvir Phosphate Capsules (Dongwei’En/Dongyangguang) – 100?mg

Emitasvir Phosphate Capsules (Dongwei’En/Dongyangguang) – 100?mg

$2.00

Dongwei’En Emitasvir Phosphate Capsules contain 100?mg per capsule and come in 28-count boxes (4 blisters of 7). Manufactured by Yichang Dongyangguang Changjiang Pharma Co., Ltd., and approved under NMPA H20200015. This NS5A inhibitor is used in hepatitis C virus (HCV) research, especially in combination with Sofosbuvir, to study viral replication, resistance, and antiviral synergy.

EMI starting from $0.00/month - View Plans
Compare

Description

Emitasvir Phosphate is an NS5A inhibitor that disrupts the HCV replication complex. The Dongyangguang formulation must be used alongside Sofosbuvir for genotype?1, non?cirrhotic chronic HCV research models . Not intended as monotherapy. While clinically used, these capsules are offered for laboratory and preclinical research in virology, biochemical assays, and pharmacology.


Product Specifications

ParameterDetails
Product NameEmitasvir Phosphate Capsules (Dongwei’En)
Generic NameEmitasvir Phosphate
Dosage FormOral capsule
Strength100?mg per capsule
Pack Size28 capsules (0.1?g × 28)
Approval NumberH20200015 (NMPA China)
ManufacturerYichang Dongyangguang Changjiang Pharma Co., Ltd.
Storage ConditionsStore ??30?°C, sealed
Intended UseLaboratory research: HCV NS5A inhibition, antiviral synergy, resistance studies

Mechanism of Action

Emitasvir Phosphate targets the HCV NS5A protein, blocking viral replication by disrupting the formation of the replication complex. Used in tandem with Sofosbuvir, it enhances antiviral efficacy against genotype 1 HCV


Research Applications

  • Genotype 1 HCV replication and inhibition assays

  • Antiviral combination therapy studies (e.g., with Sofosbuvir)

  • Resistance profiling against NS5A inhibitors

  • Pharmacokinetic and pharmacodynamics research in hepatic cells


Safety & Handling

  • For research use only—not for clinical or veterinary use

  • Handle with PPE in lab environments

  • Store as directed and discard if capsules degrade


Core Keywords

Emitasvir Phosphate capsules, DongweiEn NS5A inhibitor, HCV genotype 1 research drug, NMPA H20200015, sofosbuvir combination study, hepatitis C antiviral capsules


Research Use Disclaimer

This product is strictly for laboratory and preclinical research use. It is not approved for diagnostic, clinical, therapeutic, or veterinary use. Misuse may result in health or regulatory consequences. Use only under qualified protocols and institutional guidance.

Additional information

Weight1 kg
Dimensions26 × 23 × 26 cm

Reviews

There are no reviews yet.

Be the first to review “Emitasvir Phosphate Capsules (Dongwei’En/Dongyangguang) – 100?mg”

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare